Capricor Therapeutics Faces September 28, 2026 Deadline for Class Action Lawsuit Applications
Investors in Capricor Therapeutics, Inc. must apply by September 28, 2026, to participate in a class action lawsuit. Kahn Swick & Foti, LLC is notifying shareholders of the approaching deadline.
Capricor Therapeutics, Inc. (NasdaqGS: CAPR) investors have until September 28, 2026, to apply for inclusion in a class action securities lawsuit against the company. Law firm Kahn Swick & Foti, LLC, is informing shareholders of the critical filing deadline.
The lawsuit alleges violations of federal securities laws. The firm KSF, along with partner Charles C. Foti, Jr., is representing investors who purchased Capricor stock during a specified period and allegedly suffered losses.
Shareholders interested in participating must file a motion to be appointed lead plaintiff by the court by the September 28 deadline. KSF is providing guidance and assistance to potential claimants.
Capricor Therapeutics is a biotechnology company focused on developing therapies. The company's stock is traded on the Nasdaq under the ticker symbol CAPR.